✦ LIBER ✦

Safety and immunogenicity of a booster dose of inactivated poliovirus vaccine produced in vero-cells

✍ Scribed by Eva Haastrup; Birgit Thierry-Carstensen; Anders Mørup Jensen; Michael Stellfeld; Carsten Heilmann

Book ID: 116956967
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 78 KB
Volume: 22
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2003.09.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A booster dose of diphtheria, tetanus an

A booster dose of diphtheria, tetanus and inactivated poliovirus (dT-IPV) vaccine induces seroprotection

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Immunogenicity and safety of a new Vero

Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium

✍ Wagner A. Costa; Ricardo S. Cunha; Vera Lucia Bolzan; Andrea de Cássia R. Silva; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Immunogenicity and protective efficacy i

Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine

✍ Ede Qin; Huiying Shi; Lin Tang; Cuie Wang; Guohui Chang; Zhifen Ding; Kai Zhao; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 202 KB

Safety and immunogenicity of an inactiva

Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: A randomized trial

✍ Gerald Aichinger; Hartmut J. Ehrlich; John G. Aaskov; Sandor Fritsch; Christiane 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 488 KB

Safety and immunogenicity of a quadrival

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults

✍ Pépin, Stéphanie; Donazzolo, Yves; Jambrecina, Alen; Salamand, Camille; Saville, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 852 KB

Single dose inactivated hepatitis A vacc

Single dose inactivated hepatitis A vaccine: Rationale and clinical assessment of the safety and immunogenicity

✍ Dr. P. van Damme; C. Matheï; S. Thoelen; A. Meheus; A. Safary; F. E. André 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 537 KB

## Abstract In comparison with the classical immunisation schedules (0‐1‐6 or 0‐1‐12 months) for hepatitis A, a 0‐ and 12‐ or a 0‐ and 6‐month schedule would have important advantages by reducing the number of injections and discomfort and increasing scheduling convenience and patient compliance. I